DMT310, a novel once-weekly topical treatment for patients with moderate-to-severe acne vulgaris: Results of a phase 2b randomized, double-blind, placebo-controlled trial
-
Published:2023-11
Issue:5
Volume:89
Page:945-951
-
ISSN:0190-9622
-
Container-title:Journal of the American Academy of Dermatology
-
language:en
-
Short-container-title:Journal of the American Academy of Dermatology
Author:
Eichenfield Lawrence F.ORCID,
DuBois Janet C.,
Gold Michael H.,
Nardo Christopher J.,
Draelos Zoe D.,
Armas E.,
DeValle O.,
Haber R.S.,
Jones T.,
Kempers S.E.,
Knoepp T.G.,
Kuttner B.J.,
Lieberman R.,
Miller M.L.,
Stewart D.M.,
Weinberg J.
Reference18 articles.
1. The psychosocial impact of acne: patients' perceptions;Koo;J Am Acad Dermatol,1995
2. The prevalence of acne in adults 20 years and older;Collier;J Am Acad Dermatol,2008
3. Large-scale worldwide observational study of adherence with acne therapy;Dreno;Int J Dermatol,2010
4. A novel approach to increasing patient outcomes and adherence;Feldman;J Drugs Dermatol,2012
5. Optimizing patient adherence: update on combination acne therapy - teens and beyond;Yentzer;J Drugs Derm,2010
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Innovations in Acne;Dermatologic Clinics;2024-09